DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,095 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,582,805 | +48.7% | 6,338 | +50.1% | 0.28% | +31.6% |
Q1 2023 | $1,064,113 | +2.4% | 4,222 | +7.8% | 0.21% | -10.2% |
Q4 2022 | $1,039,650 | +93.2% | 3,917 | +88.2% | 0.24% | -46.8% |
Q3 2022 | $538,000 | -22.3% | 2,081 | -33.2% | 0.44% | +348.5% |
Q2 2022 | $692,000 | -19.2% | 3,114 | -2.4% | 0.10% | -8.3% |
Q1 2022 | $856,000 | -45.8% | 3,191 | -33.5% | 0.11% | -50.2% |
Q4 2021 | $1,580,000 | +9.7% | 4,802 | +1.5% | 0.22% | +8.5% |
Q3 2021 | $1,440,000 | +68.2% | 4,730 | +48.2% | 0.20% | +85.2% |
Q2 2021 | $856,000 | +27.6% | 3,191 | +7.0% | 0.11% | +5.9% |
Q1 2021 | $671,000 | -3.0% | 2,983 | -4.2% | 0.10% | +3.0% |
Q4 2020 | $692,000 | +64.8% | 3,114 | +59.8% | 0.10% | +39.4% |
Q3 2020 | $420,000 | +42.9% | 1,949 | +17.3% | 0.07% | +14.5% |
Q2 2020 | $294,000 | +8.9% | 1,662 | -14.7% | 0.06% | -7.5% |
Q1 2020 | $270,000 | -67.8% | 1,948 | -64.3% | 0.07% | -62.6% |
Q4 2019 | $838,000 | -4.3% | 5,461 | -10.0% | 0.18% | -15.2% |
Q3 2019 | $876,000 | +3.8% | 6,068 | +2.8% | 0.21% | +4.5% |
Q2 2019 | $844,000 | +17.9% | 5,904 | +8.9% | 0.20% | +8.0% |
Q1 2019 | $716,000 | +27.9% | 5,420 | -0.3% | 0.19% | +9.4% |
Q4 2018 | $560,000 | -4.9% | 5,435 | +0.3% | 0.17% | +23.9% |
Q3 2018 | $589,000 | +13.5% | 5,420 | +3.1% | 0.14% | -1.4% |
Q2 2018 | $519,000 | +7.5% | 5,255 | +6.5% | 0.14% | +6.1% |
Q1 2018 | $483,000 | – | 4,936 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |